Department of Oral Medicine, Peking University School and Hospital of Stomatology, Beijing 100081, China.
Evid Based Complement Alternat Med. 2015;2015:815358. doi: 10.1155/2015/815358. Epub 2015 Feb 22.
Objective. To evaluate the beneficial effects and safety of corticosteroids combined with traditional Chinese medicine (TCM) for pemphigus. Methods. Seven electronic databases were searched to identify any potential randomized controlled trials (RCTs) or clinical controlled trials (CCTs) that compared corticosteroids with and without TCM for the treatment of pemphigus, published in any language. Remission of the mucocutaneous lesions, therapeutic duration, dosage of corticosteroids, and specific antibody titers were employed as the main outcome measures. The methodological quality of the included studies was assessed using the Cochrane Handbook for Systematic Review of Interventions and Rev Man 5.1.0 software. Results. Four RCTs with a total of 199 patients were included in the present review. Management with corticosteroids combined with TCM seemed to benefit pemphigus patients in terms of healing of lesions, prevention of complications and relapse, and reduced interferon-gamma (IFN-γ) level. The trials were not of high methodological quality. No study mentioned allocation concealment and blinding. Only one trial reported adverse events, and it indicated that the safety of corticosteroids combined with TCM was uncertain. Conclusion. There is some, albeit weak, evidence to show that combined treatment with corticosteroids with TCM could be of benefit for some patients with pemphigus. The efficacy and safety of this combined treatment should be evaluated further in better designed, fully powered, and confirmatory RCTs.
目的。评估皮质类固醇联合中药(TCM)治疗天疱疮的疗效和安全性。
方法。检索了 7 个电子数据库,以确定任何潜在的随机对照试验(RCT)或临床对照试验(CCT),比较皮质类固醇与不联合 TCM 治疗天疱疮的疗效,语言不限。以黏膜皮肤病变的缓解、治疗持续时间、皮质类固醇剂量和特异性抗体滴度为主要观察指标。采用 Cochrane 干预系统评价手册和 Rev Man 5.1.0 软件评估纳入研究的方法学质量。
结果。本综述纳入了 4 项 RCT,共 199 例患者。与单独使用皮质类固醇相比,联合 TCM 治疗似乎更有利于天疱疮患者的皮损愈合、预防并发症和复发,以及降低干扰素-γ(IFN-γ)水平。但这些试验的方法学质量不高。没有研究提到分配隐藏和盲法。只有一项试验报告了不良反应,表明皮质类固醇联合 TCM 的安全性不确定。
结论。虽然证据较弱,但有一些证据表明皮质类固醇联合 TCM 治疗可能对某些天疱疮患者有益。这种联合治疗的疗效和安全性应在设计更好、充分有力和确证性 RCT 中进一步评估。